Table 3.
Infectious disease markers on day 13 after admission.
| Infection marker | ||
|---|---|---|
| HBs Ag | 0.1 | IU/mL |
| HCV Ab | 0.1 | S/CO |
| HEV IgM | <5 | |
| HEV IgG | <5 | |
| CMV IgM | <×10 | |
| CMV IgG | ×160 | |
| CMV antigen | Negative | |
| EBV-VCA-IgM | <×10 | |
| EBV-VCA-IgG | ×10 | |
| EBV-EBNA | <×10 | |
| HPV B19 IgM | 0.45 | |
| HPV B19 IgG | 1.13 | |
| HSV IgM | <×10 | |
| HSV IgG | ×40 | |
| HHV-6 IgM | ×10 | |
| HHV-6 IgG | ×640 | |
| Tsutsugamushi (Kato, Gilliam) IgM | <×10 | |
| Tsutsugamushi (Kato, Gilliam) IgG | <×10 | |
| Endotoxin | <1.0 | pg/mL |
| β-D-glucan | <6.0 | pg/mL |
HBs Ag – anti-hepatitis B surface antibody; HCV Ab – anti-hepatitis C antibody; CMV – Cytomegalovirus; EBV – Epstein-Barr virus; HPV B19 – human parvovirus B19; HSV – herpes simplex virus; HHV-6 – human herpesvirus 6.